Danish registry analysis of 83,326 people with type 2 diabetes reveals that tracking changes in key biomarkers over time provides superior cardiovascular disease prediction compared to single measurements. LDL-cholesterol variability showed the strongest association with CVD events, with hazard ratios exceeding 1.4, while glucose (HbA1c) and kidney function (eGFR) trajectory measures showed more modest 1.1-fold increases in risk. Over six years of follow-up, 14% experienced cardiovascular events. The research demonstrates that routine healthcare data containing repeated measurements can enhance risk stratification beyond traditional single-timepoint assessments. This approach addresses a critical gap in diabetes care, where current CVD prediction models achieve only moderate performance with C-indices around 0.7. The trajectory-based models showed minimal discrimination improvements but meaningful reclassification benefits, suggesting clinical utility for identifying high-risk patients who might be missed by conventional screening. However, as an unreviewed preprint, these findings require peer validation before clinical implementation. The work represents an incremental but practically significant advance in personalized diabetes management, potentially enabling more precise cardiovascular risk assessment using existing healthcare infrastructure without additional testing burden.